. 2025 Aug 19;48(1):607. doi: 10.1007/s10143-025-03752-2

Table 2.

Strength of association between variables and pre-resection hydrocephalus

Variables	OR	(95% CI)	p value
Age	0.99	(0.98–1.00)	0.116
Male	1.62	(1.06–2.46)	0.025^a
Duration of presenting symptoms	0.98	(0.97–0.99)	0.044^a
Presenting symptoms
IICP symptom	8.84	(5.39–14.51)	< 0.001^a
Ataxia	3.94	(2.50–6.20)	< 0.001^a
Cognitive impairment	10.63	(4.33–26.07)	< 0.001^a
Deterioration of consciousness	35.04	(4.64–264.46)	< 0.001^a
Cranial nerve dysfunction	0.35	(0.22–0.53)	< 0.001^a
Tumor pathology
Malignant	4.99	(3.01–8.28)	< 0.001^a
Schwannoma	0.44	(0.29–0.66)	< 0.001^a
Meningioma	0.61	(0.36–1.02)	0.057
Glial	1.91	(0.68–5.37)	0.220
Tumor volume	1.10	(1.08–1.13)	< 0.001^a
Posterior cranial fossa volume	1.00	(0.99–1.01)	0.416
Clival angle	1.03	(0.99–1.06)	0.790
Straight sinus angle	0.99	(0.98–1.02)	0.889
Intra-axial location	3.92	(2.53–6.05)	< 0.001^a
Midline location	1.65	(1.08–2.52)	0.022^a
Cerebellar cortex involvement	0.59	(0.38–0.92)	0.020^a
Brainstem involvement	0.85	(0.46–1.56)	0.591
Tumor enhancement	2.18	(0.45–10.61)	0.336
Heterogeneous enhancement	2.48	(1.58–3.89)	< 0.001^a
Peritumoral vasogenic edema	12.96	(8.06–20.84)	< 0.001^a
Intratumoral cyst	1.45	(0.94–2.22)	0.092

CI confidence interval, IICP increased intracranial pressure, OR odds ratio

^a p value < 0.05 indicates a statistically significant difference